Many investors would argue that Aphria (NASDAQ: APHA) is a consistent performer in a sector where volatile stock shifts are the norm. Down 10% this year, the pot stock has performed much better than the Horizons Marijuana Life Sciences ETF, which has fallen by 30% over the same period. And Aphria is nowhere near as bad of a short investment as Aurora Cannabis' stock has been for new investors, which has crashed a staggering 81% since Jan. 1.
Aphria is coming off an uninspiring quarterly report that sent its stock into a dive. Investors should be asking whether to buy shares of Aphria on its new dip, or if this could be the start of an even bigger decline. Let's take a closer look at the recent results and find out why they weren't cause for investor optimism.
Image source: Getty Images.
Source Fool.com